Mimetas

back to Directory

Mimetas

Founded
2013

Patents
10

Publications
66

Mimetas is a Dutch company based in Leiden, which specializes in developing organ-on-a-chip models for drug development. Founded in 2013, they raised $32.4M from multiple investors.

The company provides OrganoServices for compound profiling or screening in the human-relative models. Combined with their OrganoPlates, the screening can be performed for multiple compounds using just one plate.

Posts Mentioning This Company

How Industry Embraces Organ-on-Chips: A 2024 Status Report

Report highlights: We are currently at an exciting juncture where several big pharmaceutical companies have started adopting such models and conducted several exploratory studies The last 4 years have witnessed at least twofold increase in industrial validation of organ-on-chips across various fields and organ models The majority of the studies …

MIMETAS' Recent Milestones in Advancing Drug Discovery Through Organ-on-a-Chip Technology

As the pharmaceutical industry seeks innovative solutions for preclinical development, organ-on-a-chip technology has gained significant traction in recent years. This groundbreaking approach, which emerged in the early 2000s, involves the creation of miniaturized, three-dimensional cell cultures that replicate human organ function within microfluidic devices. These devices, composed of intricate networks …